TGA approves Novartis therapy for most commonly diagnosed type of early breast cancer

Matt Zeller, Novartis country president for Australia and New Zealand, said, “Over the past 35 years, and looking forward, we will continue to deliver innovative treatments to those with breast cancer. We join the national call for zero deaths from this disease in Australia." …